BioCentury
ARTICLE | Financial News

Innocrin Pharmaceuticals completes venture financing

April 20, 2015 7:00 AM UTC

Innocrin Pharmaceuticals Inc., Durham, N.C. Business: Cancer Date completed: 2015-04-14 Type: Venture financing Raised: $28 million Investors: Eshelman Ventures; Novartis Venture Funds; Lilly Ventures...